Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.54 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.45 |
| ▸ | TSHR | P16473 | 1/20 | 0.42 |
| ▸ | THRB | P10828 | 1/20 | 0.42 |
| ▸ | DNM1 | Q05193 | 2/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.40 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.40 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.40 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.40 |
| ▸ | SMPD1 | P17405 | 3/20 | 0.39 |
| ▸ | USP2 | O75604 | 1/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.39 |
| ▸ | GPR84 | Q9NQS5 | 2/20 | 0.38 |
| ▸ | FDPS | P14324 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1776413 | 1.00 | LMNA (0.54) | LMNACYP3A4TSHRTHRBDNM1 | |
| SCHEMBL8387794 | 1.00 | LMNA (0.54) | LMNACYP3A4TSHRTHRBDNM1 | |
| SCHEMBL9509191 | 1.00 | LMNA (0.54) | LMNACYP3A4TSHRTHRBDNM1 | |
| SCHEMBL20394323 | 1.00 | LMNA (0.54) | LMNACYP3A4TSHRTHRBDNM1 | |
| SCHEMBL18327083 | 1.00 | LMNA (0.54) | LMNACYP3A4TSHRTHRBDNM1 | |
| SCHEMBL1776604 | 1.00 | LMNA (0.54) | LMNACYP3A4TSHRTHRBDNM1 | |
| SCHEMBL574982 | 1.00 | LMNA (0.54) | LMNACYP3A4TSHRTHRBDNM1 | |
| SCHEMBL20253212 | 1.00 | LMNA (0.54) | LMNACYP3A4TSHRTHRBDNM1 | |
| SCHEMBL21641724 | 1.00 | LMNA (0.54) | LMNACYP3A4TSHRTHRBDNM1 | |
| SCHEMBL9233922 | 1.00 | LMNA (0.54) | LMNACYP3A4TSHRTHRBDNM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024142920-A1 | OIL-IN-WATER EMULSION COSMETIC | 株式会社 資生堂 | 2024-07-04 | — | — | WO | disclosed |
| CN-108743410-B | Liquid cosmetic | 株式会社资生堂 | 2023-07-21 | — | — | CN | disclosed |
| US-20200239801-A1 | ETHER COMPOUNDS AND RELATED COMPOSITIONS | CASTROL LTD (GB) | 2020-07-30 | — | — | US | disclosed |
| US-10669499-B2 | Ether compounds and related compositions | CASTROL LIMITED (GB) | 2020-06-02 | — | — | US | disclosed |
| US-20200115651-A1 | Ether-Based Lubricant Compositions, Methods and Uses | CASTROL LIMITED (GB) | 2020-04-16 | — | — | US | disclosed |
| US-20200102521-A1 | Ether-Based Lubricant Compositions, Methods and Uses | CASTROL LIMITED (GB) | 2020-04-02 | — | — | US | disclosed |
| EP-3351611-A1 | REFRIGERATION MACHINE OIL, COMPOSITION FOR REFRIGERATION MACHINES, AND COMPRESSION-TYPE REFRIGERATION MACHINE | Idemitsu Kosan Co., Ltd (JP) | 2018-07-25 | — | — | EP | disclosed |
| US-20180163150-A1 | ETHER COMPOUNDS AND RELATED COMPOSITIONS | CASTROL LIMITED (GB) | 2018-06-14 | — | — | US | disclosed |
| US-20180163150-A1 | ETHER COMPOUNDS AND RELATED COMPOSITIONS | CASTROL LIMITED (GB) | 2018-06-14 | — | — | US | disclosed |
| EP-1905505-B1 | Methods of manufacturing emulsions | FUJIFILM CORP (JP) | 2011-07-13 | — | — | EP | disclosed |
| EP-1987809-A1 | Oil-in-water type emulsion composition enthaltend Retinoide | Shiseido Co., Ltd. (JP) | 2008-11-05 | — | — | EP | disclosed |
| US-20080081842-A1 | EMULSION AND METHOD OF MANUFACTURING EMULSION | FUJIFILM CORPORATION (JP) | 2008-04-03 | — | — | US | disclosed |
| EP-1905505-A2 | Method of manufacturing an emulsion, and emulsion so produced | FUJIFILM Corporation (JP) | 2008-04-02 | — | — | EP | disclosed |
| US-6210693-B1 | CONTAINING A VITAMIN A FATTY ACID ESTER, WHICH FURTHER CONTAINS AN OIL SOLUBLE ANITOXIDANT AND A HYDROPHILIC NONIONIC SURFACTANT FOR PREVENTING HYDROLYSIS | SHISEIDO COMPANY, LTD. (JP) | 2001-04-03 | — | — | US | disclosed |
| EP-0985404-A1 | OIL-IN-WATER TYPE EMULSIFIED COMPOSITIONS | SHISEIDO COMPANY LIMITED (JP) | 2000-03-15 | — | — | EP | disclosed |
| EP-0535367-A2 | Emulsified hair cosmetic composition | Kao Corporation (JP) | 1993-04-07 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10669499-B2 | Ether compounds and related compositions | C9, CNR2, CNR1 | LMNA 494/4885CYP3A4 1874/4885TSHR 3902/4885 |
| US-20200239801-A1 | ETHER COMPOUNDS AND RELATED COMPOSITIONS | C9, CNR2, CNR1 | LMNA 494/4885CYP3A4 1874/4885TSHR 3902/4885 |
| US-20180163150-A1 | ETHER COMPOUNDS AND RELATED COMPOSITIONS | C9, CNR2, CNR1 | LMNA 494/4885CYP3A4 1874/4885TSHR 3902/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.